Attendee search 

IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research.

Biotrak Capital is a healthcare-focused investment Fund with over 400M USD under management. In china but for global angle.

Jianmin Group is a integrated pharmaceutical company with a major focus on pediatric product development manufacturing, and marketing.

A Chengdu Based Chinese Pharmaceutical Company with focus on both Brand- Name/Generic Product Development, Manufacturing and Supply in Both Domestic and International Markets. Annual revenue is more than 175 million USD. We also have medical devices business unit starting from 2020.

Xi 'an Janssen Pharmaceutical Co., Ltd. is the largest pharmaceutical joint venture in China and the largest subsidiary of Johnson & Johnson in China. Founded in 1985, the company is headquartered in Beijing, with its production base located in Xi 'an and over 3,000 employees. The company's business includes the production and sale of high quality pharmaceuticals, mainly in the fields of gastroenterology, neuropsychiatry, allergy, pain management, anti-infection, biological agents and oncology.

成都新华海纳医疗创新股权投资中心（有限合伙）该支基金由新华瑞恒基金管理公司与雷宁博士等医疗领域专业投资团队共同发起。基金围绕创新医药、医疗器械、医疗服务领域中临床应用前景良好，市场空间巨大的早期企业，以及未来5年营业收入及净利润增长迅速，可能成为龙头企业或并购标的。其中，创新医药以早期大、小分子创新药物和海外引进创新药物为主要布局方向；医疗器械以天使轮/A轮微创外科和生物材料为重点关注对象；医疗服务领域将以高性能生物材料研发平台、医疗互联网平台和医疗人工智能平台为主。

Guangdong Fengle Group Co., Ltd. (hereinafter referred to as “Fengle Group”), established in 2004, is a diversified and comprehensive industrial group corporation integrated of industry, commerce and Finance.
Fengle Group focuses on energy, new energy, energy conservation and environmental protection, industrial investment and holding, and supply chain finance, optimizing strategic layout and business structure.
Fengle group joined new fields of urban renewal, rural revitalization, medical technology, modern agriculture and animal husbandry etc. while expanding its traditional businesses.
Fengle Group headquartered in Zengcheng district, Guangzhou, then set up five management headquarters in South China, North China, East China, Southwest and Northwest China, achieving nationalization of region and products.
Fengle Group operates in more than 10 countries and regions and creates an annual output value of more than 10 billion yuan.
Guangzhou Fengle Medical Technology Co., Ltd. was founded by the parent company Guangdong Fengle Group Co.,Ltd. The face mask plant of Fengle Medical covers an area of 15,000 square meters, equipped with automatic mask production equipment, automatic packaging equipment, inspection and testing equipment.
Fengle Medical has been established with fine industry, adhering to the philosophy of value discovery, innovation and enlightenment, dedication and altruism, people-oriented, harmony and honesty, cooperation and sharing, innovation and win-win. It provides customers with a full range of quality and value-added services to achieve customer satisfaction, company satisfaction, social satisfaction. Due to rigorous, scientific, efficient and reasonable management system, the company's operation is more standardized, that become a leader in the local industry, developing steadily, rapidly and efficiently.
At present, the company's main products are: Disposable protective masks, disposable children's masks, disposable medical masks, medical surgical masks, KN95 protective masks etc. All the products have obtained the full performance Inspection and Test Report, in line with the relevant national standards and requirements. The company has obtained the ISO 13485 quality system certification, obtained the European Union CE certification, the United States FDA listing for the record, and listed in the "China Chamber of Commerce for Import and Export of Medicines and Health Products Double White List".
Health care is a sunrise industry forever. Fengle Group will take Fengle Medical Technology Co., Ltd as the starting point to build a comprehensive and integrated medical health industry base in the region by connecting with Zhongguancun and the provincial venture capital medical devices, classification diagnosis and treatment, remote diagnosis, health, research and development, and venture capital big data resources.

A pioneer investment bank focusing on all tracks of potential targets

Shanghai Junshi

早期创业投资，关注医疗健康方向。